Search - tctmd.com

Displaying 201 - 220 of 364

Sort: Relevancy | Date

News Opinion Off Script

Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation

Charles C. Hong, MD, PhD

February 04, 2022

News Conference News THT 2022

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

L.A. McKeown

February 03, 2022

News Conference News THT 2022

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

Shelley Wood

February 02, 2022

News Conference News THT 2022

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Shelley Wood

February 01, 2022

Presentation THT 2022

Should SGLT2 Inhibitors Be Started in the Hospital or in the Ambulatory Setting?

Presenter: Piotr Ponikowski

February 01, 2022

News Features

Realistic Expectations Emerge After Initial Excitement Over Xenotransplant

Yael L. Maxwell

January 21, 2022

News Daily News

Journal of Cardiac Failure Launches Rapid Publication Platform to Spark Discourse

Todd Neale

January 21, 2022

News Opinion Fellow Talk

A Trainee’s Perspective on the First Genetically Engineered Pig-to-Human Cardiac Xenotransplantation

Corbin E. Goerlich, MD

January 13, 2022

News Features

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

Shelley Wood

December 13, 2021

News Daily News

Smartphone App Hears Speech Changes Indicating Fluid Buildup in HF

Caitlin E. Cox

December 10, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for November 2021

Shelley Wood

November 30, 2021

News Conference News PCR London Valves 2021

Promising Early Results for TriClip in Tricuspid Regurgitation: bRIGHT Registry

Shelley Wood

November 24, 2021

News Conference News AHA 2021

Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE

Shelley Wood

November 14, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Conference News TCT 2021

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

Michael O'Riordan

November 06, 2021

News Conference News EACTS 2021

TAVI Registries Offer Outcome Clues as Low-Risk Numbers Climb

Shelley Wood

October 20, 2021

News Daily News

As Amyloidosis Field Explodes, Physicians Need to Spot and Treat

Todd Neale

October 20, 2021

News Features

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

Shelley Wood

October 08, 2021

News Daily News

Studies Highlight Rarity of Myocarditis With mRNA COVID-19 Vaccines

Todd Neale

October 06, 2021

News Daily News

VALVENOR Study Helps Clarify Risks in Moderate AS Patients

L.A. McKeown

October 01, 2021

Advertisement

Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Should SGLT2 Inhibitors Be Started in the Hospital or in the Ambulatory Setting?

Realistic Expectations Emerge After Initial Excitement Over Xenotransplant

Journal of Cardiac Failure Launches Rapid Publication Platform to Spark Discourse

A Trainee’s Perspective on the First Genetically Engineered Pig-to-Human Cardiac Xenotransplantation

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

Smartphone App Hears Speech Changes Indicating Fluid Buildup in HF

TCTMD’s Top 10 Most Popular Stories for November 2021

Promising Early Results for TriClip in Tricuspid Regurgitation: bRIGHT Registry

Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

TAVI Registries Offer Outcome Clues as Low-Risk Numbers Climb

As Amyloidosis Field Explodes, Physicians Need to Spot and Treat

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

Studies Highlight Rarity of Myocarditis With mRNA COVID-19 Vaccines

VALVENOR Study Helps Clarify Risks in Moderate AS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content